How have LFVN shares performed in 2024?

LifeVantage's stock was trading at $6.00 on January 1st, 2024. Since then, LFVN stock has increased by 11.0% and is now trading at $6.66. View the best growth stocks for 2024 here .

Are investors shorting LifeVantage?

LifeVantage saw a decrease in short interest in March. As of March 31st, there was short interest totaling 63,700 shares, a decrease of 21.7% from the March 15th total of 81,400 shares. Based on an average daily volume of 35,000 shares, the short-interest ratio is presently 1.8 days. Approximately 0.6% of the company's shares are sold short. View LifeVantage's Short Interest .

When is LifeVantage's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our LFVN earnings forecast .

How were LifeVantage's earnings last quarter?

LifeVantage Co. (NASDAQ:LFVN) issued its earnings results on Tuesday, January, 30th. The company reported $0.10 EPS for the quarter. The firm had revenue of $51.62 million for the quarter. LifeVantage had a net margin of 1.40% and a trailing twelve-month return on equity of 19.96%.

How often does LifeVantage pay dividends? What is the dividend yield for LifeVantage?

LifeVantage announced a quarterly dividend on Thursday, January 25th. Investors of record on Friday, March 1st will be paid a dividend of $0.035 per share on Friday, March 15th. This represents a $0.14 annualized dividend and a yield of 2.10%. The ex-dividend date of this dividend is Thursday, February 29th. Read our dividend analysis for LFVN .

Is LifeVantage a good dividend stock?

LifeVantage (NASDAQ:LFVN) pays an annual dividend of $0.14 per share and currently has a dividend yield of 2.24%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 60.87%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for LFVN .

What is Darren Jensen's approval rating as LifeVantage's CEO?

5 employees have rated LifeVantage Chief Executive Officer Darren Jensen on Glassdoor.com . Darren Jensen has an approval rating of 79% among the company's employees.

What other stocks do shareholders of LifeVantage own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF) , Acer Therapeutics (ACER) , Immunomedics (IMMU) , Arena Pharmaceuticals (ARNA) , Enphase Energy (ENPH) , NewAge (NBEV) , Catalyst Biosciences (CBIO) , Chesapeake Energy (CHKAQ) and ConocoPhillips (COP) .

How do I buy shares of LifeVantage?

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Positive News SentimentPositive News

NASDAQ:LFVN

LifeVantage (LFVN) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free LFVN Stock Alerts

$6.66

+0.06 (+0.91%)

(As of 04/18/2024 ET)

Compare

Today's Range: $6.57
▼
$6.70
50-Day Range: $5.75
▼
$7.01
52-Week Range: $3.04
▼
$8.69

Volume: 23,350 shs
Average Volume: 34,262 shs
Market Capitalization: $85.71 million

P/E Ratio: 28.96
Dividend Yield: 2.10%
Price Target: N/A

Get LifeVantage alerts:

LifeVantage MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.62% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -1.50
Upright™ Environmental Score
News Sentiment: 1.92
Based on 2 Articles This Week
Insider Trading: Acquiring Shares
$3,143 Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.17 out of 5 stars

Medical Sector

356th out of 918 stocks

Pharmaceutical Preparations Industry

151st out of 402 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for LifeVantage.

5.0

Short Interest

Percentage of Shares Shorted
0.62% of the float of LifeVantage has been sold short.
Short Interest Ratio / Days to Cover
LifeVantage has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in LifeVantage has recently decreased by 21.74%, indicating that investor sentiment is improving significantly.

1.7

Dividend Strength

Dividend Yield
LifeVantage pays a meaningful dividend of 2.24%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
LifeVantage has only been increasing its dividend for 1 years.
Dividend Coverage
The dividend payout ratio of LifeVantage is 60.87%. This payout ratio is at a healthy, sustainable level, below 75%.

2.7

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
LifeVantage has received a 20.78% net impact score from Upright. LifeVantage seems to create the most significant positive value in categories "Taxes", "Physical diseases", and "Jobs". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Plant-based fatty acid supplements", "Probiotics", and "Herbal dietary supplements" products. See details.
Environmental Sustainability
The Environmental Impact score for LifeVantage is -1.50.

3.8

News and Social Media Coverage

News Sentiment
LifeVantage has a news sentiment score of 1.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for LifeVantage this week, compared to 1 article on an average week.
MarketBeat Follows
1 people have added LifeVantage to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LifeVantage insiders have bought more of their company's stock than they have sold. Specifically, they have bought $3,143.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 6.76% of the stock of LifeVantage is held by insiders.
Percentage Held by Institutions
Only 35.32% of the stock of LifeVantage is held by institutions.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of LifeVantage is 28.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 144.19.
Price to Earnings Ratio vs. Sector
The P/E ratio of LifeVantage is 28.96, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 254.29.
Price to Book Value per Share Ratio
LifeVantage has a P/B Ratio of 2.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About LifeVantage Stock (NASDAQ:LFVN)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

LFVN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LFVN Stock News Headlines

April 18, 2024 | globenewswire.com

LifeVantage to Announce Third Quarter Fiscal Year 2024 Results on May 2, 2024

April 5, 2024 | finance.yahoo.com

Investing in LifeVantage (NASDAQ:LFVN) a year ago would have delivered you a 98% gain

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

March 20, 2024 | investing.com

Lifevantage director Darwin Lewis buys shares worth $3,142

March 18, 2024 | globenewswire.com

LifeVantage Wraps Up Momentum Academy 2024 with a Focus on Entrepreneurship and Growth

March 15, 2024 | finance.yahoo.com

Is Now The Time To Look At Buying LifeVantage Corporation (NASDAQ:LFVN)?

March 9, 2024 | finance.yahoo.com

LFVN Jun 2024 10.000 call

March 4, 2024 | globenewswire.com

LifeVantage Transforms the Future of Skin Health and Radiance: Introducing the TrueScience® Activated Skin Care Collection

April 19, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

February 24, 2024 | finance.yahoo.com

Interested In LifeVantage's (NASDAQ:LFVN) Upcoming US$0.035 Dividend? You Have Four Days Left

February 22, 2024 | wsj.com

Lifevantage Corp.

February 16, 2024 | msn.com

TCTM, LFVN, THS among consumer staples movers

February 16, 2024 | finance.yahoo.com

LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference

February 16, 2024 | globenewswire.com

LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference

February 15, 2024 | finance.yahoo.com

LifeVantage Appoints Dayton Judd to the Board of Directors

February 15, 2024 | globenewswire.com

LifeVantage Appoints Dayton Judd to the Board of Directors

February 7, 2024 | markets.businessinsider.com

LifeVantage Announces Expansion of LV360 into Canada, Mexico, and European Markets

February 6, 2024 | finance.yahoo.com

Are LifeVantage Corporation's (NASDAQ:LFVN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

February 1, 2024 | finance.yahoo.com

LifeVantage Corporation (NASDAQ:LFVN) Q2 2024 Earnings Call Transcript

January 31, 2024 | finanznachrichten.de

LifeVantage Corporation: LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2024

January 30, 2024 | msn.com

LifeVantage Non-GAAP EPS of $0.10 beats by $0.06, revenue of $51.6M misses by $3.05M

January 30, 2024 | markets.businessinsider.com

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2024

January 29, 2024 | msn.com

LifeVantage Q2 2024 Earnings Preview

January 29, 2024 | benzinga.com

Earnings Outlook For Lifevantage

January 29, 2024 | markets.businessinsider.com

Lifevantage is about to announce its earnings — here's what Wall Street expects

January 17, 2024 | stocknews.com

Will These 3 Medical Stocks Make Gains in 2024?

January 16, 2024 | finance.yahoo.com

LifeVantage to Announce Second Quarter Fiscal Year 2024 Results on January 30, 2024

See More Headlines

Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 1/30/2024
Ex-Dividend for 3/15 Dividend: 2/29/2024
Dividend Payable: 3/15/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/02/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:LFVN
CUSIP: N/A
CIK: 849146
Web: www.lifevantage.com
Phone: (801) 432-9000
Fax: 801-880-0699
Employees: 248
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.23
Trailing P/E Ratio: 28.96
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $2.54 million
Net Margins: 1.40%
Pretax Margin: 1.87%
Return on Equity: 19.96%
Return on Assets: 9.48%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.68
Quick Ratio: 1.03

Sales & Book Value

Annual Sales: $213.40 million
Price / Sales: 0.40
Cash Flow: $0.55 per share
Price / Cash Flow: 12.07
Book Value: $2.71 per share
Price / Book: 2.46

Miscellaneous

Outstanding Shares: 12,870,000
Free Float: 11,998,000
Market Cap: $85.71 million
Optionable: Optionable
Beta: 0.78

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. Steven R. Fife (Age 63)
President, CEO & Director
Comp: $882.36k
Mr. Carl A. Aure (Age 51)
Chief Financial Officer
Comp: $534.78k
Ms. Julie Boyster (Age 39)
Chief Marketing Officer
Comp: $434.62k
Mr. Eric E. Marchant
Vice President of Compliance
Ms. Alissa Neufeld (Age 45)
General Counsel & Corporate Secretary
Comp: $362.65k
Chris Taylor
Director of Communications
Ms. Kristen Cunningham (Age 40)
Chief Sales Officer
Ms. Michelle Oborn-Virchow (Age 44)
Chief People Officer
Comp: $242.09k
Ms. Calli Mott
Senior Vice President of Distributor Experience
Mr. Eiichi Shiokawa
Managing Director - Japan

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

LFVN Stock Analysis - Frequently Asked Questions

How have LFVN shares performed in 2024?: LifeVantage's stock was trading at $6.00 on January 1st, 2024. Since then, LFVN stock has increased by 11.0% and is now trading at $6.66.
View the best growth stocks for 2024 here.
Are investors shorting LifeVantage?: LifeVantage saw a decrease in short interest in March. As of March 31st, there was short interest totaling 63,700 shares, a decrease of 21.7% from the March 15th total of 81,400 shares. Based on an average daily volume of 35,000 shares, the short-interest ratio is presently 1.8 days. Approximately 0.6% of the company's shares are sold short.
View LifeVantage's Short Interest.
When is LifeVantage's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our LFVN earnings forecast.
How were LifeVantage's earnings last quarter?: LifeVantage Co. (NASDAQ:LFVN) issued its earnings results on Tuesday, January, 30th. The company reported $0.10 EPS for the quarter. The firm had revenue of $51.62 million for the quarter. LifeVantage had a net margin of 1.40% and a trailing twelve-month return on equity of 19.96%.
How often does LifeVantage pay dividends? What is the dividend yield for LifeVantage?: LifeVantage announced a quarterly dividend on Thursday, January 25th. Investors of record on Friday, March 1st will be paid a dividend of $0.035 per share on Friday, March 15th. This represents a $0.14 annualized dividend and a yield of 2.10%. The ex-dividend date of this dividend is Thursday, February 29th.
Read our dividend analysis for LFVN.

Is LifeVantage a good dividend stock?: LifeVantage (NASDAQ:LFVN) pays an annual dividend of $0.14 per share and currently has a dividend yield of 2.24%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 60.87%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for LFVN.
What is Darren Jensen's approval rating as LifeVantage's CEO?: 5 employees have rated LifeVantage Chief Executive Officer Darren Jensen on Glassdoor.com. Darren Jensen has an approval rating of 79% among the company's employees.
What other stocks do shareholders of LifeVantage own?: Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF), Acer Therapeutics (ACER), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA), Enphase Energy (ENPH), NewAge (NBEV), Catalyst Biosciences (CBIO), Chesapeake Energy (CHKAQ) and ConocoPhillips (COP).
How do I buy shares of LifeVantage?: Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LFVN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

LifeVantage (LFVN) Stock Price, News & Analysis

LifeVantage MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About LifeVantage Stock (NASDAQ:LFVN)

LFVN Stock Price History

LFVN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

LFVN Stock Analysis - Frequently Asked Questions

Overall MarketRank^™